1. Home
  2. CLLS vs AZ Comparison

CLLS vs AZ Comparison

Compare CLLS & AZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLLS
  • AZ
  • Stock Information
  • Founded
  • CLLS 1999
  • AZ 2018
  • Country
  • CLLS France
  • AZ Canada
  • Employees
  • CLLS N/A
  • AZ N/A
  • Industry
  • CLLS Biotechnology: Pharmaceutical Preparations
  • AZ Industrial Machinery/Components
  • Sector
  • CLLS Health Care
  • AZ Industrials
  • Exchange
  • CLLS Nasdaq
  • AZ Nasdaq
  • Market Cap
  • CLLS 299.0M
  • AZ 319.5M
  • IPO Year
  • CLLS 2007
  • AZ N/A
  • Fundamental
  • Price
  • CLLS $3.85
  • AZ $5.21
  • Analyst Decision
  • CLLS Buy
  • AZ Strong Buy
  • Analyst Count
  • CLLS 1
  • AZ 1
  • Target Price
  • CLLS $8.00
  • AZ $20.00
  • AVG Volume (30 Days)
  • CLLS 73.5K
  • AZ 356.6K
  • Earning Date
  • CLLS 11-07-2025
  • AZ 11-13-2025
  • Dividend Yield
  • CLLS N/A
  • AZ N/A
  • EPS Growth
  • CLLS N/A
  • AZ N/A
  • EPS
  • CLLS N/A
  • AZ N/A
  • Revenue
  • CLLS $82,551,000.00
  • AZ $7,489,000.00
  • Revenue This Year
  • CLLS N/A
  • AZ $1,343,857.60
  • Revenue Next Year
  • CLLS $58.00
  • AZ N/A
  • P/E Ratio
  • CLLS N/A
  • AZ N/A
  • Revenue Growth
  • CLLS 129.04
  • AZ 19.04
  • 52 Week Low
  • CLLS $1.10
  • AZ $5.02
  • 52 Week High
  • CLLS $5.48
  • AZ $12.36
  • Technical
  • Relative Strength Index (RSI)
  • CLLS 58.54
  • AZ 28.46
  • Support Level
  • CLLS $3.49
  • AZ $5.02
  • Resistance Level
  • CLLS $3.86
  • AZ $5.68
  • Average True Range (ATR)
  • CLLS 0.22
  • AZ 0.46
  • MACD
  • CLLS 0.03
  • AZ -0.11
  • Stochastic Oscillator
  • CLLS 89.76
  • AZ 8.08

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.

About AZ A2Z Smart Technologies Corp.

A2Z Cust2Mate Solutions Corp is engaged in creating shopping carts. With the help of a user-friendly smart algorithm, touch screen, and other technologies, the company streamlines the retail shopping experience by scanning purchased products and enabling in-cart payment so that customers can simply pick & go, and bypass long cashier checkout lines.

Share on Social Networks: